The Application Notebook
Phenomenex
When performing LC–MS-MS analysis, phospholipids are perhaps one of the most troublesome components of bioanalytical samples. The presence of phospholipids not only reduces the column lifetime and sensitivity but can also cause a phenomenon known as ion suppression.
This work compares the presence of phospholipids in plasma samples after two different sample preparation techniques, protein precipitation and simultaneous protein precipitation and phospholipid removal using a new product, Phree.
Plasma samples from the same lot were prepared (Table 1) and were injected on a Kinetex® 2.6 µm C18 core–shell column coupled with an API 3000 MS (AB SCIEX) (Figure 1). A total phospholipid profile was monitored using m/z 184–184.
Table 1: Sample preparation protocols.
When monitoring the total phospholipid profile, the protein precipitated plasma showed a large amount of phospholipids. In comparison, the plasma sample that was prepared using Phree showed virtually no phospholipids (Figure 1).
Figure 1: Total phospholipid profile.
We also studied analyte response by comparing diclofenac spiked plasma samples. After sample preparation, 20 µL samples were injected on a Kinetex® 2.6 µm C18 core–shell column. The diclofenac signal in the protein precipitated samples was immediately lower than the signal in the Phree extracted samples. The signal in the protein precipitated sample rapidly decreases. The Phree extracted sample shows a steadier signal and is able to withstand > 250 injections (Figure 2). The higher signal strength of the Phree extracted sample is due to the reduction of phospholipid induced ion suppression. The significant reduction in phospholipid build up on the column and MS source also resulted in an increase in column lifetime and a decrease in the amount of MS maintenance required.
Figure 2: Column sensitivity after 250 injections.
By preparing samples with Phree, analysts can remove proteins and phospholipids in 4 short steps resulting in immediate improvements to their chromatography work.
For more information about Phree, visit www.phenomenex.com/Phree.
Phenomenex Inc.
411 Madrid Avenue, Torrance, California 90501, USA
tel. +1 (310) 212 0555 +1 (310) 328 7768
Website: www.phenomenex.com
An LC–HRMS Method for Separation and Identification of Hemoglobin Variant Subunits
March 6th 2025Researchers from Stanford University’s School of Medicine and Stanford Health Care report the development of a liquid chromatography high-resolution mass spectrometry (LC–HRMS) method for identifying hemoglobin (Hb) variants. The method can effectively separate several pairs of normal and variant Hb subunits with mass shifts of less than 1 Da and accurately identify them in intact-protein and top-down analyses.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ions used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.